Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia

Candiolo (TO) 10060

0 studies enrolling now · 1 studies all time

What they study most

Locally Advanced or Metastatic Unresectable Urothelial Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed